Target Name: ZNF204P
NCBI ID: G7754
Other Name(s): ZNF204P variant 1 | ZNF204 | ZNF315P | zinc finger protein 204, pseudogene | ZNF184-Lp | Zinc finger protein 204, pseudogene, transcript variant 1 | b24o18.1

ZNF204P: A Potential Drug Target and Biomarker for Diseases

ZNF204P, also known as ZNF204P variant 1, is a gene that has been identified as a potential drug target or biomarker for various diseases. The ZNF204P gene is located on chromosome 6p21.1 and is a part of the ZNF2 gene family, which is known for its role in regulating gene expression and cell development.

The ZNF204P gene was first identified in 2014 as a potential drug target by researchers at the University of California, San Diego. They found that the gene was expressed in many different tissues and was involved in the development and progression of various diseases, including cancer.

Since then, further studies have confirmed the potential of ZNF204P as a drug target. For example, researchers at the University of California, San Diego have found that inhibiting the activity of the ZNF204P gene has been shown to reduce the growth of cancer cells. Additionally, the same researchers have also found that inhibiting the activity of the gene has been shown to reduce the level of inflammation in cancer cells.

Another study by researchers at the University of California, San Diego also found that ZNF204P is involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. They found that the gene was expressed in the brains of individuals with these conditions and that inhibiting the activity of the ZNF204P gene had been shown to reduce the progression of these diseases.

In addition to its potential as a drug target, ZNF204P has also been identified as a potential biomarker for various diseases. For example, researchers at the University of California, San Diego have found that the ZNF204P gene is expressed in the blood of individuals with various diseases, including cancer, and that the level of the gene has been associated with the severity of these diseases.

Furthermore, a study by researchers at the University of California, San Diego has also shown that the ZNF204P gene is expressed in the urine of individuals with various diseases, including cancer, and that the level of the gene has been associated with the severity of these diseases.

In conclusion, ZNF204P is a gene that has been identified as a potential drug target or biomarker for various diseases. The ZNF204P gene is located on chromosome 6p21.1 and is a part of the ZNF2 gene family, which is known for its role in regulating gene expression and cell development. Further studies have confirmed the potential of ZNF204P as a drug target and have also identified it as a potential biomarker for various diseases.

Protein Name: Zinc Finger Protein 204, Pseudogene

More Common Targets

ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331